RxSIGHT, INC. (RXST) stock plummeted 6.06% on Wednesday, likely due to a series of analyst rating and price target adjustments.
BTIG lowered its price target on RXST from $58 to $44, although it maintained a Buy rating. The firm's decision to lower the price target could have contributed to the stock's decline, as it reflects a more conservative valuation outlook.
Meanwhile, Stifel Nicolaus maintained a Hold rating on RXST and set a price target of $33, while Needham reiterated its $43 price target on the stock. These neutral-to-negative analyst actions may have weighed on investor sentiment, leading to the selloff in RXST shares.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。